BillionToOne, Inc. (BLLN) is in Healthcare, Diagnostics & Research, based in United States, listed on NasdaqGS. Market cap 4.50B USD. 52-week range 61.96 to 150.44 USD. Trailing P/E 151.4. Data as of 2026-10-09.
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a ...